A single blind, multicenter, randomized controlled trial to evaluate the effectiveness and cost of a novel nutraceutical (LopiGLIK®) lowering cardiovascular disease risk

• Κύριοι συγγραφείς: Manfrin A (Συγγραφέας), Trimarco V (Συγγραφέας), Manzi MV (Συγγραφέας), Rozza F (Συγγραφέας), Izzo R (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Dove Medical Press, 2018-10-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Andrea Manfrin,1 Valentina Trimarco,2,3 Maria Virginia Manzi,2,4 Francesco Rozza,2,4 Raffaele Izzo2,5 1Sussex Pharmacy, School of Life Sciences, University of Sussex, Falmer, Brighton, UK; 2Hypertension Research Centre, University of Naples Federico II, Naples, Italy; 3Department o...